Comparative validation of quantitative coronary angiography systems. Results and implications from a multicenter study using a standardized approach. by Keane, D.T.J. (David) et al.
Institution: SWETS SUBS SERVICE | Sign In via User Name/Password
Search:
Go
Advanced Search
Circulation Home
Subscriptions
Archives
Feedback
Authors
Help
AHA Journals Home
« Previous Article | Table of Contents | Next Article »
Circulation. 1995;91:2174-2183
(Circulation. 1995;91:2174-2183.)
© 1995 American Heart Association, Inc.
Articles
Comparative Validation of
Quantitative Coronary
Angiography Systems
Results and Implications From a
Multicenter Study Using a Standardized
Approach
Presented in part at the 66th Scientific Sessions of the
American Heart Association, Atlanta, Ga, November 8-11,
1993.
David Keane, MB, MRCPI; Jürgen Haase, MD,
PhD; Cornelis J. Slager, PhD; Eline Montauban
van Swijndregt, MSc; Kenneth G. Lehmann,
MD; Yukio Ozaki, MD, PhD; Carlo di Mario,
MD, PhD; Richard Kirkeeide, PhD; Patrick W.
Serruys, MD, PhD
From the Cardiac Catheterization, Intracoronary Imaging,
and Experimental Cardiology Laboratories, Thoraxcenter,
Erasmus University, Rotterdam, the Netherlands, and the
Division of Cardiology (R.K.), Health Science Center,
University of Texas, Houston.
Correspondence to Prof P.W. Serruys, MD, PhD, FESC,
Department of Interventional Cardiology, Thoraxcenter,
Erasmus University, PO Box 1738, 3000 DR Rotterdam, Netherlands.
Abstract
This Article
Abstract
Alert me when this article is cited
Alert me if a correction is posted
Citation Map
Services
Email this article to a friend
Similar articles in this journal
Similar articles in PubMed
Alert me to new issues of the journal
Download to citation manager
Request Permissions
Citing Articles
Citing Articles via HighWire
Citing Articles via Google Scholar
Google Scholar
Articles by Keane, D.
Articles by Serruys, P. W.
Search for Related Content
PubMed
PubMed Citation
Articles by Keane, D.
Articles by Serruys, P. W.
Background Computerized quantitative coronary angiography (QCA) has
fundamentally altered our approach to the assessment of coronary
interventional techniques and strategies aimed at the prevention of
recurrence and progression of stenosis. It is essential, therefore, that the
performance of QCA systems, upon which much of our scientific
understanding has become integrally dependent, is evaluated in an
objective and uniform manner.
Methods and Results We validated 10 QCA systems at core laboratories in North
America and Europe. Cine films were made of phantom stenoses of known diameter (0.5
to 1.9 mm) under four experimental conditions: in vivo (coronary arteries of pigs)
calibrated at the isocenter or by use of the catheter as a scaling device and in vitro with
50% contrast and 100% contrast. The cine films were analyzed by each automated QCA
system without observer interaction. Accuracy and precision were taken as the mean and
SD of the signed differences between the phantom stenoses, and the measured minimal
luminal diameters and the correlation coefficient (r), the SEE, the y intercept, and the
slope were derived by their linear regression. Performance of the 10 QCA systems ranged
widely: accuracy, +0.07 to +0.31 mm; precision, ±0.14 to ±0.24 mm; correlation (r), .96
to .89; SEE, ±0.11 to ±0.16 mm; intercept, +0.08 to +0.31 mm; and slope, 0.86 to 0.64.
Conclusions There is a marked variability in performance between systems when
assessed over the range of 0.5 to 1.9 mm. The range of accuracy, intercept, and slope
values of this report indicates that absolute measurements of luminal diameter from
different multicenter angiographic trials may not be directly comparable and additionally
suggests that such absolute measurements may not be directly applicable to clinical
practice using an on-line QCA system with a different edge detection algorithm. Power
calculations and study design of angiographic trials should be adjusted for the precision of
the QCA system used to avoid the risk of failing to detect small differences in patient
populations. This study may guide the fine-tuning of algorithms incorporated within each
system and facilitate the maintenance of high standards of QCA for scientific studies.
Key Words: angiography • coronary disease • stenosis
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Clinical trials incorporating quantitative coronary angiography (QCA)
have made a significant impact on the practice of interventional
cardiology. They have reported the results of vessel size, lesion severity,
and short- and long-term angiographic outcome of patients undergoing
interventional procedures. On the basis of the BENESTENT, STRESS,
CAVEAT, and CCAT trials, angiographic guidelines have been proposed
for the application of interventional devices.1 2 3 4 Furthermore, on the
basis of restenosis prevention studies such as MARCATOR, PARK, and the US
Angiopeptin trial and of progression-regression studies, pharmacological agents have
been deemed to be ineffective because by the QCA approach a difference in minimal
luminal diameter at follow-up has not been detected.5 6
The results of these trials, however, have been generated by different off-line QCA
systems. It is not known whether their results are all of equal reliability and to what extent
each system overestimates or underestimates the true coronary dimensions. To determine
the reliability of the angiographic results of interventional, restenosis, and progression-
regression trials, a validation of 10 QCA systems at major core angiographic laboratories
in North America and Europe (including the core laboratories that performed the QCA for
all of the above-mentioned trials) was undertaken.
QCA systems with poor precision may fail to detect small but significant differences in
study populations, whereas QCA systems with poor accuracy may provide misleading
results of absolute measurements of minimal luminal diameter. The results of studies
based on unreliable QCA systems may not be directly comparable to those of more
reliable systems. To render the results of angiographic studies meaningful and universally
applicable, it is important that QCA systems be validated in a systematic and standardized
fashion. Results of single-center validation studies will vary according to the individual
characteristics of the models of the phantom stenoses used and their radiographic
acquisition.7 8 9 10 Without a standardized approach to validation, it becomes difficult to
assess to what degree individual angiographic studies are reliable, the significance of their
failure to detect relative changes in minimal luminal diameter, and how much weight
should be attributed to absolute values of minimal luminal diameter derived from
individual QCA systems. Furthermore, it is only by detailed validation studies that errors
in QCA measurements can be identified and thereby provide guidance for the refinement
of QCA systems.
To assess the QCA systems under radiographic conditions reflecting clinical practice in
addition to those of optimal radiographic acquisition, phantom stenoses of known
diameter were used as a reference both in vivo (after insertion in the coronary arteries of
pigs) and in vitro (Plexiglas blocks). The QCA systems were assessed by their
measurement of the absolute value (in millimeters) of the minimal luminal diameter
within the artificial stenoses, which has previously been shown to be more reliable than
relative measures (percent diameter stenosis) of coronary artery dimensions based on the
definition of a reference contour.11 12 13
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Methods
Phantom Stenoses
The phantom stenoses used in vivo as well as in vitro consisted of radiolucent acrylate
and polyamide cylinders with precision-drilled circular lumens 0.5, 0.7, 1.0, 1.4, and 1.9
mm in diameter. Optical calibration of the stenosis channels using 40-fold magnification
gave a tolerance of 0.003 mm. Parallel to the stenosis lumen, a second lumen 1.3 mm in
diameter was drilled in the cylinders to enable their attachment to the tip of 4F Fogarty
catheters (Vermed). The lumens of the Fogarty catheters contained a removable metallic
stylet, which aided the intracoronary insertion of the phantoms as well as their positioning
in the radiographic isocenter. Details of our experimental approach to QCA validation
have been described.14 15 16
In Vivo Studies
The procedures followed were in accordance with institutional guidelines for animal
studies. The phantom stenoses were inserted into the coronary arteries of anesthetized
Yorkshire pigs (45 to 50 kg). Twelve-French introducer sheaths were surgically placed in
both carotid arteries to allow the sequential insertion of the phantom stenoses on 4F
Fogarty catheters and the insertion of the angiographic guiding catheter. To minimize the
effect of respiration on angiographic acquisition, mechanical ventilation was temporarily
discontinued immediately before each contrast injection. With two methods of
calibration, two series of measurements were obtained for the in vivo series, providing an
assessment of the variability of nonisocentric calibration.
In Vitro Studies
The phantom stenoses were serially inserted into a Plexiglas acrylate model to
approximate the attenuation and beam hardening (peak kilovolt [kVp] level, 75 kV)
produced by the human thorax.17 18 The Plexiglas channel, including the artificial
stenosis, was then filled with contrast medium (iopamidol 370, Bracco; 370 mg
iodine/mL) at concentrations of 50% and then 100%. Each phantom stenosis filled with
contrast medium was recorded on cine film. By use of two concentrations of contrast
medium, two series of measurements were obtained for the in vitro series, allowing an
assessment of the variability introduced by contrast concentration.
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Calibration
All the in vitro cine frames were calibrated off-line by scaling from a steel object of 3-
mm diameter recorded at the radiographic isocenter as previously described.14 15 16 Both
the 3-mm scaling object and subsequently the in vitro phantom stenoses were filmed
precisely at the isocenter of the x-ray system.19 The calibration procedures available in
each off-line QCA system were applied to the images obtained by automated edge
detection to produce the corresponding calibration factors (millimeters per pixel).
All in vivo frames were calibrated by scaling from the isocentric 3-mm steel object;
subsequently, the analysis was repeated and frames were calibrated by scaling from the
angiographic catheter, which was achieved by the nonisocentric radiographic acquisition
of the unfilled tip of the contrast catheter (positioned at the coronary ostium as in routine
clinical practice). A recent study using a centimeter grid showed that QCA measurements
correspond to the outer diameter of the catheter and that the use of contrast-empty
catheters (-2.9%) yields more accurate results than contrast-filled catheters (-7.1%).20 21
The diameter of the nontapering part of each 8F polyurethane catheter was measured
(diameters of the individual catheters ranging from 2.49 to 2.54 mm) with a precision
micrometer (No. 293-501, Mitutoyo; accuracy, 0.001 mm), resulting in the respective
calibration factors (millimeters per pixel). In the in vivo series, after the intracoronary
insertion of each phantom stenosis and before angiographic recording, the radiopaque tip
of the guide wire of the Fogarty catheter that was located in the side channel of each
phantom was used as a marker in two planes to ensure that the phantom stenosis lay at the
radiographic isocenter. The guide wire was then removed before coronary angiography.
Image Acquisition and Processing
A monoplane Philips Poly Diagnost C2 machine equipped with an MRC x-ray tube and
powered by an Optimus CP generator (Philips Medical Systems International BV) was
used for all radiographic imaging. The 5-in (12.5-cm) field mode of the image intensifier
(focal spot, 0.8 mm) was selected, and the radiographic system settings were kept
constant (kVp, mA, ms) in each projection. All phantoms were imaged in two projections
sequentially and acquired on 35-mm cine film (CFE type 2711, Kodak) at a frame rate of
25 images per second with an Arritechno 90 cine camera (Arnold & Richter) with an 85-
mm lens. The cine films were processed by a Refinal developer (Agfa-Gavaert) for 4
minutes at 28°C. The film gradient was measured in all cases to ensure that the optical
densities of interest were on the linear portion of the sensitometric curve. From each
angiogram that fulfilled the requirements of quantitative analysis (no superimposition of
surrounding structures, no major vessel branching at the site of the phantom), a
homogeneously filled end-diastolic coronary image was selected. Ten in vitro and 19 in
vivo frames were suitable for quantitative analysis of the artificial stenoses.
Quantitative Angiographic Analysis
The cine films of the phantom stenoses were analyzed off-line by 10 QCA systems in
nine participating centers. Each center had a unique combination of QCA software and
hardware. The default settings of optical magnification, light-emitting diode settings, etc,
at each core laboratory were used without alteration. It is assumed in this study that each
core laboratory (through continuous internal quality control assessments) has established
for itself the optimal settings and operations for its individual QCA system. The resultant
pixel size after digitization depended on the video camera pixel matrix (Table 1 ) of each
system and ranged from 0.07 to 0.20 mm/pixel. The list of participating centers and
details of their QCA systems are given in alphabetical order in Table 1 (it should be
noted that the subsequent results for the 10 systems are given in a different order
anonymously). None of the QCA systems tested had been previously calibrated at prior
validation testing with the type of phantom used. One of the investigators (E.M.v.S.)
visited all the centers, bringing the same set of films for analysis to each center
consecutively. The same set of preselected cine frames was analyzed at each center to
avoid the introduction of any variability between QCA systems associated with frame
selection by each operator.22 A technician working at each center who was unaware of the
true diameters of the phantom stenoses performed the automated QCA analysis of all cine
frames in the presence of the investigator. To maintain scientific objectivity and to ensure
that the direct comparisons between the 10 QCA systems were valid, operator
intervention or editing of the automated edge detection was not permitted. An example of
a contrast-filled phantom stenosis in vivo and its subsequent contours outlined by one of
the QCA systems is given in Fig 1 .
View this table:
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[in a new window]
Table 1. Details of QCA Systems
View larger version (112K):
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Figure 1. The borders of a coronary segment
containing a phantom stenosis are outlined by the
automated edge-detection algorithm of one of the
validated quantitative coronary angiography
systems. Diameter function is plotted at bottom of
figure.
Statistical Analysis
The individual geometric measurements of minimal luminal diameter were compared
with the true phantom diameters by simple subtraction and by linear regression analysis.
The mean of the signed differences between measured values and the known diameter of
the phantom stenoses was considered an index of accuracy and the SD of the differences
an index of precision.
Results
The individual indexes of accuracy and precision are given for all four validation series
(in vivo with two calibration techniques and in vitro with two contrast concentrations)
along with the average of their unsigned (absolute) values for all 10 QCA systems
validated in Table 2 . The averages for accuracy and precision, for correlation coefficient
and SEE, and for intercept and slope for all 10 QCA systems are given in Table 3 .
View this table:
[in this window]
[in a new window]
Table 2. Accuracy and Precision
View this table:
[in this window]
[in a new window]
Table 3. Summary of Validation Results
Indexes of Agreement
Accuracy of the 10 QCA systems ranged from 0.07 to 0.31 mm, and the correlation
coefficient ranged from .96 to .89. The intercept of the regression line was positive for all
10 QCA systems and ranged from +0.08 to +0.31 mm, whereas the slope of the regression
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line for all 10 QCA systems was <1.0 and ranged from 0.86 to 0.64. Application of these
regression lines indicates percentage accuracies for the 10 QCA systems ranging from
+26% to -1% (mean, +7.2%) for measurements of lumen diameters of 0.5 mm,
percentage accuracies from -7% to -24% (mean, -14.9%) for lumen diameters of 1.5 mm,
and percentage accuracies from -11% to -29% (mean, -20.5%) for lumen diameters of 3.0
mm.
Indexes of Noise and Consistency
Precision of the 10 QCA systems ranged from ±0.14 to ±0.24 mm, and the SEE ranged
from ±0.11 to ±0.16 mm.
An indication of the variability of performance among the 10 QCA systems can be
visualized by comparing the results of the in vivo test calibrated by the catheter for two of
the systems depicted in Fig 2 .
View larger version (20K):
[in this window]
[in a new window]
Figure 2. Graph showing in vivo data for two of
the quantitative coronary angiography (QCA)
systems validated. An indication of the variability
of performance of the QCA systems validated is
demonstrated by linear regression of the results for
QCA systems 5 and 9. The raw data for the in vivo
QCA analysis calibrated by the catheter as a scaling
device has been plotted on the y axis with the true
phantom stenosis diameters on the x axis. Each data
point represents a single analysis of a cine frame
from each angiographic sequence. The accuracy
was -0.19 mm for system 5 and -0.33 mm for
system 9; the precision was ±0.13 mm for system 5
and ±0.26 mm for system 9; the correlation was .98
for system 5 and .91 for system 9; and the SEE was
±0.09 mm for system 5 and ±0.14 mm for system 9.
Influence of the Validation Model
As expected, it can be seen in Table 2 that the performance of each individual system
varied from one validation test to another. In the in vivo series, accuracy was better when
calibrated at the isocenter than on catheter calibration in all 10 systems validated (see Fig
3 ). The method of calibration did not influence the precision or SEE of QCA. In the in
vitro series, both accuracy and the SEE were found to improve when the concentration of
the injected contrast was 100% compared with 50% during validation of 8 of the 10
systems.
View larger version (46K):
[in this window]
[in a new window]
Figure 3. Bar graph showing effect of calibration
on accuracy of the in vivo series. The accuracy of
quantitative coronary angiography (QCA) is seen to
improve during calibration at the isocenter
compared with the use of the angiographic catheter
as a scaling device. Solid bars indicate catheter;
shaded bars, isocenter.
Discussion
This study demonstrates the wide range of performance provided by 10 QCA systems
currently in use in North America and Europe. The clinical implications of such widely
different results are considerable and can be divided into the clinical implications of
inaccuracy and the clinical implications of imprecision of QCA measurements.
Clinical Implications of QCA Inaccuracy
All systems were found to have a positive intercept (>0) and a slope of <1, indicating that
many clinical studies to date using QCA may have overestimated the baseline minimal
luminal diameter of their study populations and underestimated the acute gain in minimal
luminal diameter after coronary intervention. For example, with QCA system 9, the linear
regression analysis of which is displayed in Fig 2 , a vessel of 2-mm diameter will be
reported as 1.31 mm, and a procedural improvement in minimal luminal diameter from
0.5 to 1.9 mm will be reported as a luminal gain of only 0.77 mm. This may result in the
establishment of angiographic guidelines that, when directly adopted in clinical practice
using on-line QCA,7 14 23 24 may lead to device-vessel mismatching and inappropriately
aggressive luminal gains and when adopted in subsequent clinical trials may lead to
inappropriate inclusion criteria. By underestimation in the range of typical reference
vessel diameters (in addition to overestimation in the range of typical minimal luminal
diameters), clinical studies reporting their QCA results exclusively in terms of percent
diameter stenosis will be less instructive than studies disclosing the absolute values of the
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minimal luminal diameter. These findings contrast with visual assessments of luminal
diameter, which tend to overestimate acute luminal gain (it should be noted, however,
that the variability between visual measurements has previously been shown to be many
times higher than between QCA measurements25 26 27 28 ).
Measurements by some QCA systems were so different from the true phantom diameters
and so different from other QCA systems that the direct pooling of absolute angiographic
data from different core laboratories may be rendered invalid. Although little could be
done to correct for the random error in QCA results before the sharing of data between
core angiographic laboratories, application of a corrective function could be applied to
compensate (recalibrate) for the known systematic errors of each QCA system.
Specifically, the regression formula [y=a+b(x)] derived from standardized validation
studies of each QCA system could be applied to the results of angiographic trials, thereby
normalizing to an intercept of 0 and a slope of 1 for each core laboratory [corrected
result=(measurement result-intercept)/slope]. Such a step might facilitate the meta-
analysis of complementary intervention studies such as STRESS and BENESTENT or
such as CAVEAT and CCAT.
Clinical Implications of QCA Imprecision
It could be proposed that poor accuracy or consistent overestimation or underestimation
of absolute luminal diameters does not inherently abrogate the value of QCA in the
detection of changes in serial angiographic studies, and perhaps the inherent noise
(random error) of the system is more important for clinical trials. The high absolute
values for precision (up to ±0.30 mm) and SEE (up to ±0.22 mm) provided by some
systems indicate that calculation of study power and sample size for clinical studies
should differ from one angiographic core laboratory to another. For example, for a two-
limb angiographic restenosis study, a population size of 1022 patients would be required
if QCA system 5 (precision, ±0.13 mm) were used, whereas a population size of 1356
patients would be required if QCA system 10 (precision, ±0.30 mm) were used to detect a
difference in loss of minimal luminal diameter at follow-up of 0.10 mm (providing a
value of =.05 and a power of 90% and allowing for a patient dropout rate of 15%).6 29 30
However, it should be acknowledged that the value of precision reflects not only the
random error of measurements but also the systematic errors of a measurement system.31
It may therefore be more appropriate to use the known SEE of a QCA system for the
power calculations of clinical trials rather than the value of precision of the QCA system.
In the absence of such adjustments in study design, differences between study groups may
go undetected or fail to reach statistical significance if a QCA with a large random error
is used.
The effect of the precision of a QCA system on the ability to clearly detect a difference
among study populations can be seen graphically in Fig 4 , in which a hypothetical study
population has been analyzed by two different QCA systems, one with a poor precision
and one with a good precision (the mathematical analysis used Lotus 1-2-3, Release 2.0
for Windows, Lotus 1993): The patient populations in graphs A and D are identical and
represent a hypothetical study population in a restenosis trial 6 months after coronary
intervention; one group of patients (treated with placebo) has "restenosis" (mean change
in minimal luminal diameter at follow-up of 1.0 mm), and the other group does not have
"restenosis" (mean change in minimal luminal diameter at follow-up of 0.0 mm) after
successful treatment with a drug. Graphs B and E display the precision (0.08 and 0.30
mm) of two hypothetical QCA systems used to analyze the above study populations.
Graphs C and F show the resultant measurements of the same study population by the two
different QCA systems. In graph C, the significant difference between the two treatment
groups (placebo and active drug) has been clearly detected by the highly precise QCA
system. In graph F, the difference between the treatment groups has been lost (or the
difference does not reach statistical significance) when analyzed by the imprecise QCA
system. Similarly, a bimodal distribution of luminal renarrowing within a population may
appear as unimodal when assessed by an imprecise QCA system.32
View larger version (19K):
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Figure 4. Graphs showing the effect of the
precision of quantitative coronary angiography
(QCA) systems on the ability to clearly detect a
difference among study populations when a
hypothetical study population (graphs A and D) has
been analyzed by two different QCA systems: one
with good precision (graph B) and one with poor
precision (graph E). The difference between the
treated and placebo patients has been detected
(graph C) by the precise QCA system, whereas
analysis by the imprecise QCA system (graph F)
fails to detect the difference or fails to reach
statistical significance (the mathematical analysis
used Lotus 123, Release 2.0 for Windows, Lotus
1993). MLD indicates minimal luminal diameter.
In Vivo Versus In Vitro Data
The tables of results provided in this report contain an average of the four validation tests
for each QCA system. It is debatable, however, whether the results of in vivo tests (in
which veiling glare and scatter are heterogeneous because of overlying structures) and in
vitro tests (in which veiling glare and scatter are homogeneous) calibrated by different
methods should be grouped together and thus attributed equal importance in view of their
unique characteristics and implications.17 18 Correlation between the different validation
series was poor; however, this was to be expected, given the different combinations of
hardware and software components of the 10 QCA systems (eg, different weightings of
the first and second derivative would be expected to respond differently to the sharper
change in brightness profile associated with 100% contrast or using a steel object for
calibration). Although the contrast of the steel object was sharp, it was on the linear
portion of the sensitometric curve, and, indeed, rather than resulting in a greater
underestimation of stenosis measurements, QCA measurements calibrated by the steel
object were associated (to a major or minor degree) with less underestimation of true
diameters compared with catheter calibration, as shown in Table 2 and Fig 3 . This
finding of improved accuracy most likely results from the isocentric location of the steel
calibration device rather than the catheter, which lay in the coronary ostium proximal to
the coronary segment containing the stenosis as in clinical practice (with subsequent out-
of-plane magnification). The results of the in vivo validation test calibrated by the
catheter most closely reflect the practice of off-line analysis as performed in multicenter
angiographic trials by a core laboratory, and in most of the 10 systems these results were
poorer than those of the other three validation tests.
Influence of Hardware and Software Components of Each QCA System
The influence of the camera and cine-video converter on the final result of QCA analysis
is highlighted by this study, which showed that although three centers had the same
software package, remarkably different results were obtained because of their unique
combinations of hardware components. Although our study was not designed to
determine which components of the QCA chain were responsible for introducing the most
noise, it is clear from our results that a core laboratory conducting follow-up studies
should revalidate its QCA system whenever a hardware or software component is
exchanged or upgraded.33 34 This is of particular relevance to progression-regression
trials, in which a QCA system 4 years old is likely to have been upgraded at the core
laboratory by more modern versions of the software.
Positive Directions and the Future of QCA
The results of this study have already been used by the producers of some of the QCA
systems to refine the algorithms incorporated within each system. Many of the systematic
errors detected can be corrected by recalibration of the QCA software or tuning of the
weighting of the first to the second derivative in the edge-detection algorithm,35 36
whereas it would be expected to be more difficult to clear a system of noise, which
usually reflects hardware impediments. Experimental algorithms currently under
development include an adaptive dynamic weighting of the first and second derivatives to
overcome the problem of overestimating measurements of small vessels and
underestimating measurements of large diameters37 37A and a gradient field transform
incorporating a "shortest-path" algorithm rather than a traditional smoothing "minimal-
cost" algorithm to cope with the abrupt changes in luminal contour encountered after
coronary angioplasty.38
Given the considerable time, effort, and cost of conducting restenosis and progression-
regression trials, it seems reasonable to aim for a precision of clinical QCA measurements
of 0.20 mm for the analysis of current multicenter angiographic studies. It is hoped that
such an arbitrary threshold could be reduced over coming years when high-resolution
digital x-ray cameras and high-resolution digital export formats (with lossless
compression) are widely available at all investigating centers. An additional proposal that
could be considered for clinical studies to reduce the variability of QCA measurements
would be for the investigators to reduce the setting of the focal spot size of the x-ray
source to its smallest value (currently 0.4 mm in most x-ray systems) for the recording of
the individual angiograms of patients participating in angiographic trials. Other steps for
the reduction of variability of QCA measurements and the standardization of
angiographic acquisition have been described in detail.37 39 40 41 42 43
Despite the variabilities in QCA measurements highlighted by this study, we should
remain appreciative of the increased understanding of coronary artery disease afforded to
us by the widespread application of QCA to scientific research and clinical practice. QCA
has alleviated the subjectivity and high variability of visual assessments,26 28 44 45 46 the
errors and invalidity of the percent diameter stenosis for the assessment of
progression/regression (pseudoprogression),12 25 43 and the limitations of the dichotomous
approach for the evaluation of restenosis.13 31 47 48 49 50 51 52 53 54 55 56 The provision by
QCA of objective and absolute measurements of coronary luminal diameter has
significantly enhanced our approach to the assessment of noninvasive and invasive
coronary interventions. It is hoped that the findings of our study will serve as a stimulus
for the further improvement of QCA so that it may remain the gold standard and
complementary technique to the new intracoronary imaging modalities for the acute and
serial assessment of coronary artery dimensions.
Study Limitations
Although this study assessed the variability of measurements provided by automated
QCA of a standardized set of cine films, it does not quantify the additional variability that
might be introduced by variation in patient position and x-ray gantry settings during serial
angiographic studies40 57 (although this is now minimized by the design of most current
trial protocols), the recording and developing of cine films at different institutions, frame
selection (although this is now standardized by selection of end-diastolic frames22 41 ), and
the occasional manual correction of detected contours (although this should be kept to an
absolute minimum in angiographic core laboratories). The cumulative imprecision,
including these factors, has been quantified in two clinical studies using one of the QCA
systems validated and has been found in both studies to be ±0.20 mm (SD of
measurements of serial angiograms).25 58
It can be seen in Fig 1 that although the contours of our phantom stenoses possessed an
abrupt (90°) onset and termination, they were smooth over their 8-mm length. In clinical
practice, many lesions are irregular, with rapidly changing arterial boundaries after
coronary intervention. Given the use of a smoothing minimal-cost algorithm along scan
lines perpendicular to the axis of the vessel, currently available QCA systems might be
expected to fare less favorably if challenged with dissections and complex lesions
compared with the angiographic stenoses presented in our study. Initial results with an
experimental gradient-field transform algorithm provide hope that future QCA systems
might be able to cope with more complex lesions.38 This could perhaps be best tested in
future validation studies by postmortem casts of diseased human coronary arteries with
ulcerated plaques, dissections, and complex morphology.
The diameters of the phantom stenoses in this study (0.5 to 1.9 mm) were in the range of
obstruction diameters of human coronary stenoses rather than typical reference vessel
size. It is noteworthy that the average minimal luminal diameters before, immediately
after, and at 6-month follow-up are 1.03, 1.78, and 1.48 mm for balloon angioplasty,29
0.98, 2.03, and 1.47 mm for directional coronary atherectomy,3 and 1.07, 2.5, and 1.83
mm for stent implantation.1 The positive intercept values of the regression line for all the
systems in this study indicate that most QCA systems tend to overestimate in the lower
range of luminal diameters (<1 mm). The slope (b), however, was <1 for all systems,
indicating that for larger reference vessels, the QCA systems tested would underestimate
the true lumen diameter. A standardized set of phantoms of large diameter should be
produced for future multicenter studies to comprehensively examine the performance of
QCA systems over the complete range of vessel size. The intracoronary insertion of
phantom stenoses of large diameter may, however, prove to be difficult in the porcine
model in view of the limited size of the coronary artery lumen.
Conclusions
This study has revealed wide differences in the performance of currently available QCA
systems, highlighting the difficulties in attempting to make direct comparisons between
absolute measurements of one angiographic study and those derived from a different
QCA system or with on-line analysis in clinical practice. Power calculations and study
design of angiographic trials should be adjusted for the precision of the QCA system used
to avoid the risk of failing to detect small differences in patient populations.
QCA validation studies should be performed in a uniform and standardized manner to
provide meaningful data that can be used to compare the performance of QCA systems, to
guide the recalibration of QCA algorithms, and to facilitate the maintenance of high
standards of QCA for clinical practice and scientific studies. The entire chain of a QCA
system should be revalidated each time the version of QCA software is upgraded or a
hardware component is exchanged.
In the reporting of angiographic studies, absolute values of luminal diameter and values
of statistical significance for differences between study populations should be
accompanied by the results of the appropriate validation parameters of the QCA system
used so as to facilitate the interpretation of clinical studies.
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